Unlocking Critical Rare Earths and High-Grade Gold in a Top-Tier Jurisdiction
Sorrento Resources begins drilling at its Newfoundland gold projects, with high-grade soil anomalies and visible gold supporting exploration upside.
Proprietary laser technologies that are disrupting traditional material processing methods
Laser Photonics CEO discusses growth strategy, backlog expansion, and opportunities across aerospace, defense and industrial markets.
One of the best silver intercepts in the world year to date
Group Eleven Resources reports one of the strongest silver intercepts globally this year. CEO Bart Jaworski discusses drilling, jurisdiction advantages and exploration plans in…
A strategically important mineral playing a critical role in clean energy technologies
Boron One outlines the strategic importance of boron in clean energy, its high-grade European project, licensing progress, and development milestones.
Mullen Group discusses 2025 results and 2026 plan
Mullen Group reviews 2025 results, balance sheet strength, Cole acquisition, dividend growth and its disciplined acquisition strategy for 2026.
Globex Mining takes a very different approach to mineral exploration and development
In this Capital Compass episode, Globex Mining discusses its diversified exploration strategy, portfolio of over 200 assets, royalty exposure, and opportunities in gold and…
A project generator designed to limit dilution, share risk, and create opportunities
Avrupa Minerals discusses its project generator model, copper-zinc exploration in Finland and Portugal, joint ventures, and plans to limit dilution while advancing multiple assets.
At the intersection of immersive gaming, health, and artificial intelligence
In this episode of The Capital Compass, we’re taking a look at Virtuix Inc. (NDAQ:VTIX) —...
Record highs for gold, silver, and copper! But tungsten is really taking off! Almonty shares are eclipsing Barrick Mining and MP Materials!
Commodity prices are running wild. But anyone who thinks that developments in gold and silver are...
Developing a neurosciences platform with potential applications across several indications
In this Capital Compass episode, Marvel Biosciences outlines progress on MB-204, its neuroscience platform targeting autism, Rett syndrome, Fragile X, and Alzheimer’s disease ahead…